Page last updated: 2024-08-21

isoxazoles and Psychoses

isoxazoles has been researched along with Psychoses in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.35)	18.7374
1990's	14 (18.92)	18.2507
2000's	21 (28.38)	29.6817
2010's	38 (51.35)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alphs, L; Amatniek, J; Canuso, CM; Deutsch, SI; Henderson, DC; Mao, L; Mikesell, C; Rodriguez, S; Sheehan, J	1
Alphs, L; Bossie, CA; Fu, DJ; Sheehan, JJ; Turkoz, I	1
Conway, C; Cristancho, P; Jewkes, D; Mon, T	1
Chiu, NY; Hsu, WY	1
Cavanna, AE; Seri, S	1
Attard, A; Cornelius, V; Curtis, V; Olofinjana, O; Taylor, D	1
Olofinjana, O; Taylor, D	1
Hou, YC	1
Creus, M; Franch, J; Gutiérrez-Zotes, A; Labad, J; Lawrie, SM; Monseny, R; Montalvo, I; Ortega, L; Reynolds, RM; Vilella, E	1
Jayathilake, K; Johnson, R; Kwentus, J; Lindenmayer, JP; Meltzer, HY; Share, DB	1
Hou, YC; Lai, CH	1
Morrissette, DA; Stahl, SM	1
Alphs, L; Canuso, CM; Fu, DJ; Lindenmayer, JP; Schooler, NR; Simonson, RB; Turkoz, I; Walling, DP	1
Buckley, PF	1
Gopalakrishna, G; Ithman, M; Lauriello, J	1
Bäuml, J; Förstl, H; Gebhart, C; Hüther, R; Mirisch, S	1
Aburashed, R; Bhatt, A; Farooq, MU; Kassab, MY; Moore, PW	1
Graff-Guerrero, A; Kapur, S; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H	1
Kumar, R; Sachdev, PS	1
Chen, CH; Chiu, CC; Huang, MC; Lai, YC; Pan, CH; Tsai, CJ	1
Järbrink, K; Knapp, M; Locklear, J	1
Kecskés, I	1
Asada, T; Mizukami, K; Sato, S	1
Manoj, P; Skopek, M	1
Bossie, CA; Canuso, CM; Carothers, J; Kosik-Gonzalez, C; Lindenmayer, JP; Schooler, NR; Turkoz, I	1
English, C; Harrington, CA	1
Bossie, CA; Canuso, CM; Carothers, J; Kosik-Gonzalez, C; Lindenmayer, JP; Schooler, N; Turkoz, I; Walling, D	1
López-Díaz, LM; Martínez Pérez-Balsa, A; Vadillo-Olmo, FJ	1
Battisti, WP; Canuso, CM	1
Choi, IG; Jon, DI; Jung, MH; Kim, JN; Lee, BC	1
Boncompagni, G; Lateana, D; Mandrioli, R; Mercolini, L; Raggi, MA	1
Calarge, CA; Miller, del D	1
Adelsky, M; Adler, DN; Brenner, R; Madhusoodanan, S; Serper, MR	1
Yang, LP	1
Case, M; Hoffmann, VP; Jacobson, JG	1
Grant, JS; Keltner, NL; Moore, RL	1
Citrome, L; Hochfeld, M; Meng, X; Stahl, SM	1
Lane, HY; Teng, PR	1
Bies, RR; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsunoda, K; Uchida, H; Watanabe, K	1
Coffey, MJ	1
Fukatsu, N; Kanemoto, K; Kato, H; Noguchi, T; Oshima, T	1
Fukui, N; Inoue, Y; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	1
Huang, YC; Liang, CS; Yang, FW	1
Franch, J; Labad, J; López, X; Monseny, R; Montalvo, I; Ortega, L; Solé, M; Vilella, E	1
Chanachev, A; Conus, P; Despland, JN; Eap, CB; Ebbing, K; Herrera, F; Mall, JF; von Gunten, A	1
Ancione, M; D'Arrigo, C; Madia, A; Migliardi, G; Morgante, L; Spina, E; Zoccali, R	1
Aichhorn, W; Stuppaeck, C; Whitworth, AB	1
Baselmans, P; Bosker, F; Bruggeman, R; Castelein, S; Knegtering, R; van den Bosch, RJ	1
Chan, YH; Chong, SA; Tan, CH; Verma, SK	1
Kapur, S; Labelle, A; Mamo, D; Mann, S; Mannaert, E; Reiss, J; Remington, G; Shammi, C	1
Hendset, M; Nesvåg, R; Refsum, H; Tanum, L	1
Oberpichler-Schwenk, H	1
Melkersson, KI	1
D'Hoore, P; Kushner, S; Mannaert, E; Remmerie, B; Thyssen, A	1
Crocq, MA; Duval, F; Garcia Duarte, F; Guillon, MS; Mokrani, MC	1
Awouters, FH; Lewi, PJ	1
Cutler, AJ; Polymeropoulos, MH; Weiden, PJ; Wolfgang, CD	1
Litman, RE; Potkin, SG; Torres, R; Wolfgang, CD	1
Ford, B; Greene, P; Lynch, T	1
Cozza, SJ; Edison, DL	1
Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP	1
Silva, JA; Smith, EA; Tekell, JL	1
McCarthy, RH; Terkelsen, KG	1
Dave, M	1
Devane, CL; Risch, SC; Tyson, SC	1
Remr, J	1
Cesková, E; Svestka, J	1
Katz, IR; Streim, J	1
Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM	1
Allikmets, L; Matto, V; Pruus, K; Rudissaar, R; Skrebuhhova-Malmros, T	1
Benkert, O; Hillert, A; Maier, W; Wetzel, H	1
Gelders, YG; Heylen, SL; Janssen, PA; Reyntjens, AJ; Vanden Bussche, G	1
Burton, P; Gelders, Y; Heylen, S; Mesotten, F; Pietquin, M; Suy, E	1

Reviews

11 review(s) available for isoxazoles and Psychoses

Article	Year
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression. Journal of affective disorders, 2013, Aug-15, Volume: 150, Issue:1 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Severity of Illness Index	2013
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS spectrums, 2014, Volume: 19, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence	2014
Therapeutic role of zonisamide in neuropsychiatric disorders. Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:10 Topics: Adult; Animals; Anticonvulsants; Child; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Psychotic Disorders; Retrospective Studies; Zonisamide	2008
Akathisia and second-generation antipsychotic drugs. Current opinion in psychiatry, 2009, Volume: 22, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles	2009
Tolerability of paliperidone: a meta-analysis of randomized, controlled trials. International clinical psychopharmacology, 2010, Volume: 25, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia	2010
Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:15 Topics: Animals; Bipolar Disorder; Delayed-Action Preparations; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Oral paliperidone: a review of its use in the management of schizoaffective disorder. CNS drugs, 2011, Jun-01, Volume: 25, Issue:6 Topics: Administration, Oral; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Treatment Outcome	2011
[Psychiatry]. Revue medicale suisse, 2013, Jan-09, Volume: 9, Issue:368 Topics: Antipsychotic Agents; Depression; Electroconvulsive Therapy; Humans; Isoxazoles; Mythology; Paliperidone Palmitate; Palmitates; Psychiatry; Psychotherapy; Psychotic Disorders	2013
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Compliance; Patient Satisfaction; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Solubility; Tablets; Taste; Therapeutic Equivalency	2007
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen. Arzneimittel-Forschung, 2007, Volume: 57, Issue:10 Topics: Antipsychotic Agents; Haloperidol; History, 20th Century; History, 21st Century; Humans; Isoxazoles; Paliperidone Palmitate; Pimozide; Psychotic Disorders; Pyrimidines; Risperidone; Structure-Activity Relationship	2007
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Suppl 1 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Humans; Isoxazoles; Long QT Syndrome; Male; Middle Aged; Patient Dropouts; Piperidines; Prospective Studies; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Weight Gain	2008

Trials

14 trial(s) available for isoxazoles and Psychoses

Article	Year
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression. Journal of affective disorders, 2013, Aug-15, Volume: 150, Issue:1 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Severity of Illness Index	2013
A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia. Schizophrenia research, 2014, Volume: 154, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2014
Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Placebos; Pregnancy; Psychotic Disorders; Recurrence; Secondary Prevention; Treatment Outcome; Young Adult	2015
A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:5 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Treatment Outcome	2010
Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:5 Topics: Adult; Affect; Antidepressive Agents; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Treatment Outcome	2010
Use of paliperidone in elderly patients with schizophrenia and schizoaffective disorder: a prospective open-label short-term pilot study. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3 Topics: Aged; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Schizophrenia	2011
Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:2 Topics: Adolescent; Adult; Aged; Algorithms; Amantadine; Antipsychotic Agents; Benzodiazepines; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Metformin; Middle Aged; Olanzapine; Psychotic Disorders; Schizophrenia; Weight Gain; Zonisamide	2012
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. Human psychopharmacology, 2012, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2012
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study. Therapeutic drug monitoring, 2012, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Nonlinear Dynamics; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult	2012
Plasma risperidone concentrations during combined treatment with sertraline. Therapeutic drug monitoring, 2004, Volume: 26, Issue:4 Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline	2004
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. Psychopharmacology, 1995, Volume: 117, Issue:1 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon	1995
Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Pharmacopsychiatry, 1993, Volume: 26, Issue:4 Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology	1993
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 10, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome	1999
Pilot clinical investigation of risperidone in the treatment of psychotic patients. Pharmacopsychiatry, 1990, Volume: 23, Issue:5 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Evaluation; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychotic Disorders; Risperidone	1990

Other Studies

50 other study(ies) available for isoxazoles and Psychoses

Article	Year
Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease. Clinical schizophrenia & related psychoses, 2014, Volume: 8, Issue:1 Topics: Antipsychotic Agents; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Isoxazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Schizophrenia; Treatment Outcome	2014
Successful use of right unilateral ECT for catatonia: a case series. The journal of ECT, 2014, Volume: 30, Issue:1 Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder, Major; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Isoxazoles; Lorazepam; Lupus Erythematosus, Systemic; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Schizophrenia, Catatonic; Seizures; Treatment Outcome; Young Adult	2014
Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:5 Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Time Factors	2013
Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities. Epilepsy & behavior : E&B, 2013, Volume: 29, Issue:2 Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Electroencephalography; Epilepsy; Female; Humans; Isoxazoles; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Psychotic Disorders; Zonisamide	2013
Paliperidone palmitate long-acting injection--prospective year-long follow-up of use in clinical practice. Acta psychiatrica Scandinavica, 2014, Volume: 130, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychotic Disorders; Pyrimidines; Schizophrenia; Treatment Outcome; Young Adult	2014
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization. International clinical psychopharmacology, 2014, Volume: 29, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Monitoring; Electronic Health Records; Female; Follow-Up Studies; Hospitals, Urban; Humans; Isoxazoles; Length of Stay; London; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Patient Acceptance of Health Care; Patient Compliance; Psychotic Disorders; Recurrence; Schizophrenia; Young Adult	2014
Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder. The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1 Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Social Behavior Disorders	2014
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis. PloS one, 2014, Volume: 9, Issue:2 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cognition; Cognition Disorders; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Young Adult	2014
Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient. The Journal of neuropsychiatry and clinical neurosciences, 2014, Apr-01, Volume: 26, Issue:2 Topics: Adult; Antipsychotic Agents; Appetite; Body Weight; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone	2014
Drug development update. Clinical schizophrenia & related psychoses, 2015, Volume: 8, Issue:4 Topics: Antipsychotic Agents; Drug Approval; Humans; Isoxazoles; Paliperidone Palmitate; Palmitates; Psychotic Disorders; United States; United States Food and Drug Administration	2015
Does indication drive use, or does use drive indication? The Journal of clinical psychiatry, 2015, Volume: 76, Issue:3 Topics: Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Placebos; Pregnancy; Psychotic Disorders; Secondary Prevention	2015
Choreatic symptoms during and after treatment with paliperidone and escitalopram. Pharmacopsychiatry, 2008, Volume: 41, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chorea; Citalopram; Depressive Disorder, Major; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines	2008
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cross-Sectional Studies; Dopamine Antagonists; Female; Humans; Isoxazoles; Male; Middle Aged; Ontario; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome	2009
Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders. Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome; White People	2009
Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Current medical research and opinion, 2009, Volume: 25, Issue:7 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Dibenzothiazepines; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Placebos; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult	2009
[Successful quetiapine therapy in psychotic patients with mood elevation]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2009, Volume: 11, Issue:4 Topics: Adult; Affect; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Euphoria; Female; Humans; Isoxazoles; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain	2009
Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Aged; Basal Ganglia Diseases; Female; Humans; Isoxazoles; Lewy Body Disease; Psychotic Disorders; Treatment Outcome; Zonisamide	2010
Hyperprolactinaemia during treatment with paliperidone. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2010, Volume: 18, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Galactorrhea; Humans; Hyperprolactinemia; Isoxazoles; Middle Aged; Paliperidone Palmitate; Patient Compliance; Piperazines; Prolactin; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Quinolones; Recurrence; Schizophrenia, Paranoid; Young Adult	2010
[Psychosis due to zonisamide: an infrequent case]. Revista de neurologia, 2010, Sep-16, Volume: 51, Issue:6 Topics: Aged; Anticonvulsants; Humans; Isoxazoles; Psychotic Disorders; Zonisamide	2010
Paliperidone-induced leukopenia and neutropenia: a case report. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Leukopenia; Neutropenia; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines	2011
Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jan-15, Volume: 879, Issue:2 Topics: Chromatography, Liquid; Humans; Isoxazoles; Linear Models; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity; Solid Phase Microextraction; Spectrophotometry, Ultraviolet	2011
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2 Topics: Adolescent; Aging; Antipsychotic Agents; Body Mass Index; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Polypharmacy; Psychotic Disorders; Pyrimidines; Risperidone; Sex Factors; Sexual Development	2011
Biological perspectives: update on newer antipsychotic drugs: are they evidence based? Perspectives in psychiatric care, 2011, Volume: 47, Issue:4 Topics: Antipsychotic Agents; Cyclooxygenase 2 Inhibitors; Dibenzocycloheptenes; Evidence-Based Medicine; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoindoles; Isoxazoles; Lactones; Lurasidone Hydrochloride; Piperidines; Psychotic Disorders; Pyridines; Serotonin Receptor Agonists; Sulfones; Thiazoles	2011
Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. The Journal of neuropsychiatry and clinical neurosciences, 2011,Fall, Volume: 23, Issue:4 Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone	2011
Catatonia and encephalopathy associated with paliperidone palmitate. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2 Topics: Aged; Antipsychotic Agents; Catatonia; Female; Humans; Isoxazoles; Lorazepam; Male; Neuroleptic Malignant Syndrome; Palmitates; Psychotic Disorders; Pyrimidines; Schizophrenia	2012
Impact of antiepileptic drugs on genesis of psychosis. Epilepsy & behavior : E&B, 2012, Volume: 23, Issue:4 Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Complex Partial; Female; Follow-Up Studies; Humans; International Classification of Diseases; Isoxazoles; Male; Middle Aged; Phenytoin; Psychotic Disorders; Retrospective Studies; Young Adult; Zonisamide	2012
Effect of the cytochrome P450 2D610 allele on risperidone metabolism in Japanese psychiatric patients. Human psychopharmacology, 2012, Volume: 27, Issue:1* Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult	2012
Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:5 Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Parkinsonian Disorders; Psychotic Disorders; Pyrimidines; Substance Withdrawal Syndrome; Syndrome	2012
Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate. International clinical psychopharmacology, 2013, Volume: 28, Issue:1 Topics: Adult; Age Factors; Antipsychotic Agents; Biomarkers; Drug Substitution; Female; Humans; Hyperprolactinemia; Injections; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recovery of Function; Risperidone; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult	2013
Risperidone and breast-feeding. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:2 Topics: Adult; Antipsychotic Agents; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Postpartum Period; Psychotic Disorders; Pyrimidines; Risperidone	2005
Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels. The American journal of psychiatry, 2005, Volume: 162, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone	2005
Plasma risperidone levels and clinical response in patients with first-episode psychosis. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Asian People; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Treatment Outcome	2005
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. The American journal of psychiatry, 2006, Volume: 163, Issue:3 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Corpus Striatum; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Prolactin; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia	2006
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication. Acta psychiatrica Scandinavica, 2006, Volume: 114, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome	2006
[Paliperidone]. Medizinische Monatsschrift fur Pharmazeuten, 2006, Volume: 29, Issue:8 Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Schizophrenia	2006
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite. Human psychopharmacology, 2006, Volume: 21, Issue:8 Topics: Adult; Antipsychotic Agents; Biotransformation; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia	2006
Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder. Psychoneuroendocrinology, 2008, Volume: 33, Issue:2 Topics: Adolescent; Adolescent Medicine; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone	2008
Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Suppl 1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Endpoint Determination; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia	2008
New antipsychotic agent, risperidone, introduced. American journal of hospital pharmacy, 1994, May-01, Volume: 51, Issue:9 Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone	1994
Risperidone in Parkinson's disease. Lancet (London, England), 1994, Sep-03, Volume: 344, Issue:8923 Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Psychotic Disorders; Risperidone	1994
Risperidone in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:8 Topics: Adolescent; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology	1994
Prolonged erection associated with risperidone treatment. The American journal of psychiatry, 1995, Volume: 152, Issue:7 Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Priapism; Psychotic Disorders; Risperidone	1995
Risperidone augmentation of clozapine. Pharmacopsychiatry, 1995, Volume: 28, Issue:2 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia, Paranoid; Schizophrenic Psychology	1995
Two cases of risperidone-induced neuroleptic malignant syndrome. The American journal of psychiatry, 1995, Volume: 152, Issue:8 Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Neuroleptic Malignant Syndrome; Piperidines; Primidone; Psychotic Disorders; Risperidone; Tremor	1995
Pharmacokinetic interaction between risperidone and clozapine. The American journal of psychiatry, 1995, Volume: 152, Issue:9 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone	1995
[Clinical evaluation of risperidone]. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone	1993
New drugs may help treat psychoses. Provider (Washington, D.C.), 1995, Volume: 21, Issue:7 Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Clozapine; Drug Costs; Humans; Isoxazoles; Nursing Homes; Piperidines; Psychotic Disorders; Research; United States	1995
Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats. Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:8 Topics: Aggression; Animals; Apomorphine; Baclofen; Behavior, Animal; Disease Models, Animal; GABA Agonists; Isoxazoles; Male; Neurotransmitter Agents; Psychotic Disorders; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Synaptic Transmission	2000
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach. Pharmacopsychiatry, 1992, Volume: 25, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Depressive Disorder; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Syndrome	1992
Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients. Psychopharmacology, 1989, Volume: 99, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Electrocardiography; Female; Hormones; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone	1989